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Adenosine plays a major modulatory and neuroprotective role
in the mammalian CNS. During cerebral metabolic stress, such
as hypoxia or ischemia, the increase in extracellular adenosine
inhibits excitatory synaptic transmission onto vulnerable neu-
rons via presynaptic adenosine A1 receptors, thereby reducing
the activation of postsynaptic glutamate receptors. Using a
combination of extracellular and whole-cell recordings in the
CA1 region of hippocampal slices from 12- to 24-d-old rats, we
have found that this protective depression of synaptic trans-
mission weakens with repeated exposure to hypoxia, thereby
allowing potentially damaging excitation to both persist for
longer during oxygen deprivation and recover more rapidly on
reoxygenation. This phenomenon is unlikely to involve A1 re-
ceptor desensitization or impaired nucleoside transport. In-
stead, by using the selective A1 antagonist 8-cyclopentyl-1,3-
dipropylxanthine and a novel adenosine sensor, we demonstrate
that adenosine production is reduced with repeated episodes of
hypoxia. Furthermore, this adenosine depletion can be re-
versed at least partially either by the application of exogenous
adenosine, but not by a stable A1 agonist, N
6-cyclopentyl-
adenosine, or by endogenous means by prolonged (2 hr)
recovery between hypoxic episodes. Given the vital neuropro-
tective role of adenosine, these findings suggest that depletion
of adenosine may underlie the increased neuronal vulnerability
to repetitive or secondary hypoxia/ischemia in cerebrovascular
disease and head injury.
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Extracellular adenosine in the CNS increases during pathological
stimuli such as head injury (Nilsson et al., 1990; Headrick et al.,
1994), epileptic seizures (Winn et al., 1980; Dunwiddie, 1999),
and hypoxia/ischemia (Berne et al., 1974; Rudolphi et al., 1992;
Sweeney, 1997; Von Lubitz, 1999). The increase in extracellular
adenosine inhibits glutamate release via presynaptic adenosine
A1 receptors (Fowler, 1989; Katchman and Hershkowitz, 1993;
Zhu and Krnjevic, 1993; Pearson and Frenguelli, 2000). In addi-
tion, simultaneous activation of postsynaptic A1 receptors acti-
vates a potassium conductance leading to membrane hyperpolar-
ization, thereby intensifying the magnesium block of the NMDA
subtype of glutamate receptor (Erdemli et al., 1998; Von Lubitz,
1999). Together, these actions exert a powerful neuroprotective
“retaliatory” (Newby, 1984) influence during traumatic or meta-
bolic stress.
Manipulations that increase extracellular adenosine, such as
adenosine uptake inhibition (Gidday et al., 1995), inhibition of
adenosine metabolizing enzymes (Phillis and O’Regan, 1989;
Miller et al., 1996; Jiang et al., 1997), or activation of A1 receptors
by exogenous A1 agonists (Rudolphi et al., 1992; Sweeney, 1997;
Von Lubitz, 1999; de Mendonca et al., 2000) are all neuropro-
tective. Conversely, antagonism of A1 receptors (Rudolphi et al.,
1992; Sweeney, 1997; Von Lubitz, 1999; de Mendonca et al., 2000)
and increased metabolism of extracellular adenosine (Donaghy
and Scholfield, 1994; Sweeney, 1997; de Mendonca et al., 2000)
increases neuropathology.
Despite the protective influence of endogenous adenosine,
repeated exposure to brief hypoxia/ischemia, over the period of a
few hours, results in an exacerbation of neuronal damage even if
the episodes are of such short duration (2–3 min) that they cause
no damage when administered in isolation. No explanation for
this phenomenon has been advanced despite it being a consistent
observation in studies of the effects of cerebral ischemia (Tomida
et al., 1987; Kato et al., 1989) and head injury (Jenkins et al.,
1989; Nawashiro et al., 1995). These observations imply the loss
of a homeostatic mechanism that leaves the CNS vulnerable to
subsequent hypoxia/ischemia. Indeed, it is clear from the study of
head-injured humans that secondary hypoxia/ischemia caused by
depression of central respiratory centers or occlusion or damage
of the cerebral vasculature is a major cause of neuropathology
and death (Blumbergs, 1997). Furthermore, in compromised ne-
onates, epileptic seizures are frequently associated with periods
of cerebral hypoxia (Volpe, 1995).
In this study we have examined the effects of repeated exposure
to hypoxia on excitatory synaptic transmission in CA1 neurons of
the hippocampus, widely regarded as among the most vulnerable
in the mammalian CNS to disruptions in nutrient supply. We
have shown that the adenosine-dependent depression of excita-
tory synaptic transmission during hypoxia is weakened by previ-
ous exposure to hypoxia. Direct measurement of adenosine re-
lease during hypoxia revealed reduced production of adenosine.
Received Aug. 21, 2000; revised Jan. 16, 2001; accepted Jan. 19, 2001.
We are grateful to The Wellcome Trust, The Scottish Hospital Endowment
Research Trust, Tenovus (Tayside), The Anonymous Trust (Dundee), and the
Royal Society for financial support. B.G.F. is a Caledonian Research Foundation
Fellow. We thank John Bell (Sycopel International Ltd.) for help with the design of
the adenosine biosensors.
Correspondence should be addressed to Dr. B. G. Frenguelli, Department of
Pharmacology and Neuroscience, University of Dundee, Ninewells Hospital and
Medical School, Dundee DD1 9SY, UK. E-mail: b.frenguelli@dundee.ac.uk.
Copyright © 2001 Society for Neuroscience 0270-6474/01/212298-10$15.00/0
The Journal of Neuroscience, April 1, 2001, 21(7):2298–2307
However, by giving exogenous adenosine or prolonged inter-
episode recovery intervals, the sensitivity of synaptic transmission
to hypoxia can be partially restored. Our data suggest a previously
undescribed vulnerability of adenosine production and provide a
plausible explanation for the increased sensitivity of the CNS to
the repeated insults commonly experienced in various human
neurological disorders, such as cerebrovascular disease or after
head injury.
MATERIALS AND METHODS
Slice preparation. Sprague Dawley rats of either sex, aged 12–24 d, were
killed by cervical dislocation in accordance with Schedule 1 of the UK
Government Animals (Scientific Procedures) Act 1986. After decapita-
tion, the brain was rapidly removed and placed in ice-cold artificial CSF
(aCSF) containing 11 mM Mg 21 wherein 400 mm transverse hippocampal
slices were cut with a Vibratome (IntraCel, Royston, Herts, UK) as
described previously (Dale et al., 2000). Slices were placed in an incu-
bation chamber comprising a nylon mesh within a beaker of continuously
circulating, oxygenated (95% O2/5% CO2) standard aCSF (1 mM Mg
21)
and kept at room temperature for at least 1 hr before use. The compo-
sition of the standard aCSF solution was (in mM): NaCl 124, KCl 3,
CaCl2 2, NaHCO3 26, NaH2PO4 1.25, D-glucose 10, MgSO4 1, pH 7.4
with 95% O2/5% CO2.
Extracellular recording. A single slice was transferred to a recording
chamber, fully submerged in aCSF, and perfused at 6 ml/min (32–34°C).
A theta glass (,5 MV) or twisted Teflon-coated tungsten bipolar stim-
ulating electrode (;100 mm in diameter) positioned in stratum radiatum
was used to stimulate the Schaffer collateral commissural pathway at 15
sec intervals. The stimulus intensity (;30–50% of maximum) was sub-
threshold for population spike activation. Extracellular recordings of the
evoked field EPSPs (fEPSPs) were made from stratum radiatum with
aCSF-filled glass microelectrodes (,2 MV). Electrical signals were ac-
quired at 10 kHz, filtered at 1 Hz–3 kHz, and recorded to a Pentium
computer using “LTP” data acquisition and analysis software (courtesy
of Dr. Bill Anderson and Professor Graham Collingridge, Bristol Uni-
versity, UK; www.ltp-program.com).
Measurement of extracellular adenosine and simultaneous extracellular
recording. A novel adenosine sensor was used to measure directly the
release of adenosine during hypoxia (Dale, 1998; Dale et al., 2000).
Briefly, the sensor (Sycopel International Ltd., Jarrow, Tyne & Wear,
UK) uses an enzymic cascade that sequentially converts adenosine to
inosine (adenosine deaminase; EC 3.5.4.4) to hypoxanthine (nucleoside
phosphorylase; EC 2.4.2.1) to uric acid and hydrogen peroxide (xanthine
oxidase; EC 1.1.3.22). The hydrogen peroxide is polarized on 50 mm
platinum wires located within the twin barrels of the sensor. The twin
barrels, one of which lacks adenosine deaminase, allowed differential
measurements to be made, increasing the specificity of the signal for
adenosine. The sensor (overall width ;500 mm) was placed on the
surface of area CA1 with the recording electrode within 200 mm of the
sensor. Within each experiment, frequent calibration of the sensor via
bath-application of exogenous adenosine (usually 2 mM) allowed conver-
sion of the sensor output (in nanoamperes) to units of adenosine con-
centration (cf. Dale et al., 2000). Calibration was performed either
before or shortly after a hypoxic episode under identical extracellular
ionic conditions. The output of the sensor was recorded on a chart
recorder. Field EPSPs were evoked and recorded with LTP software and
displayed on the second channel of the chart recorder.
Whole-cell patch clamp. Recordings from CA1 pyramidal neurons were
made under visual guidance (oblique illumination of slice) with a Carl
Zeiss Axioskop FS upright microscope (Carl Zeiss, Welwyn Garden
City, UK). Patch electrodes (4–8 MV) were filled with (in mM):
CeMeSO3 100, HEPES 40, NaATP 2, NaGTP 0.3, MgCl2 5, glutathione
5, EGTA 0.2, QX314 5. An aCSF-filled, glass stimulating electrode was
placed in stratum radiatum ;50 mm from the cell body layer and 50–100
mm from the patched cell. EPSCs (in the presence of 50–100 mM
picrotoxin or 10 mM bicuculline) were sampled at 10 kHz, filtered at 1
kHz, and recorded with an Axopatch-1D amplifier (Axon Instruments,
Foster City, CA). Data acquisition was under the control of LTP soft-
ware. EPSCs were evoked at 15 sec intervals, and four events (1 min of
data) were averaged. Small voltage steps (65 mV) were evoked before an
EPSC to monitor membrane and series resistance.
Induction of hypoxia. In all experiments, hypoxia was induced by the
substitution of standard aCSF with identical aCSF pre-equilibrated with
95% N2/5% CO2 as described previously (Frenguelli, 1997; Dale et al.,
2000). This manipulation reduced bath oxygen tension from ;80–90%
saturation to ,10%, as measured by a Diamond General oxygen micro-
electrode (IntraCel). The duration of hypoxia varied between 2.25 and
40 min, and up to five hypoxic episodes were given in any one experi-
ment. Tissue was exposed to a drug for at least 30 min before the
induction of hypoxia.
Chemicals. Chemicals used in the aCSF were supplied by BDH (Lut-
terworth, Leics, UK). Adenosine was supplied by both RBI (Poole,
Dorset, UK) and Sigma-Aldrich (Poole, Dorset, UK). Adenosine deami-
nase (EC 3.5.4.4), nucleoside phosphorylase (EC 2.4.2.1), xanthine oxi-
dase (EC 1.1.3.22), cesium methanesulfonate (CeMeSO3), HEPES,
EGTA, NaATP, NaGTP, MgCl2, and glutathione were obtained from
Sigma. S-(4-nitrobenzyl)-6-thioinosine (NBTI), dipyridamole (DIPY),
8-cyclopentyl-1,3-dipropylxanthine (DPCPX), N 6-cyclopentyladenosine
(N 6CPA), and lidocaine N-ethyl bromide (QX-314) were all supplied by
RBI. DPCPX and DIPY were dissolved in ethanol; the final concentra-
tion of vehicle was 0.001–0.02 and 0.05%, respectively.
Data analysis. The effects of hypoxia on synaptic transmission were
quantified in terms of the time taken for hypoxia to depress synaptic
transmission to 50% (t50) of baseline values. This figure was arrived at by
interpolation by eye, for the time taken for transmission to decay to 50%
(extracellular recording), or by sometimes fitting a single decaying ex-
ponential to the decay phase of transmission (whole-cell experiments).
T50 values of repeated synaptic depressions from individual experiments
were pooled into groups and compared using, where appropriate, paired
t test, unpaired t test, or as otherwise indicated. Significance was noted at
the level of p , 0.05. Data are presented as mean 6 SEM.
RESULTS
Hypoxia rapidly and reversibly depresses excitatory
synaptic transmission in area CA1 via the activation of
presynaptic adenosine A1 receptors
Exposure of hippocampal slices to hypoxia resulted in a rapid
depression of the fEPSP [50% depression in 80 6 2 sec (n 5 165)
and 96.4 6 1.5% depression at 5 min (n 5 114)], which was greatly
attenuated by the selective adenosine A1 antagonist DPCPX [200
nM; 23.5 6 4.5% depression at 5 min (n 5 5)] (Fig. 1).
The hypoxic depression of synaptic transmission is
delayed by subsequent exposure to hypoxia
After exposure to hypoxia and subsequent recovery of transmis-
sion, slices were re-exposed to a second hypoxic episode. We
consistently observed greater resistance of synaptic transmission
to the second hypoxic episode (Fig. 2) that manifested as a
slowing of the rate of decay of the fEPSP during hypoxia. We
termed this “conditioning” and quantified it as the difference
(Dt50) between the time to 50% depression (t50) of the first (t50(1))
and second (t50(2)) hypoxic episodes.
Brief hypoxic episodes (2.25 min) (Fig. 2B) cause an incom-
plete depression (85.0 6 4.1%; n 5 11) of the fEPSP yet still
resulted in significant conditioning (Dt50 5 12 6 3 sec; n 5 11;
paired t test, p , 0.002). Prolonging the duration of the first
hypoxic episode progressively increased the extent of condition-
ing and reduced the efficacy of hypoxia in depressing synaptic
transmission (Fig. 2B). For example, an initial 10 min hypoxic
episode induced conditioning of 48 6 2 sec (n 5 94). This
resulted in transmission being depressed by only 13.9 6 2.4%
during the second hypoxic episode at a time (1.25 min) at which
the fEPSP had been depressed by 50.1 6 4.1% during the first. At
the longest time point tested, an initial hypoxic episode of 40 min
duration resulted in conditioning of 78 6 4 sec (n 5 27). The
extent of conditioning, when plotted against the duration of the
initial hypoxic episode, appeared to achieve an asymptote. In-
deed, such a relation could be fitted by a simple exponential
function Dt50 5 T‘ (1 2 e
2t / t), where T‘, the maximal amount of
Pearson et al. • Adenosine Depletion and Replenishment in Area CA1 J. Neurosci., April 1, 2001, 21(7):2298–2307 2299
conditioning, was 80.2 sec, and t, the time constant of condition-
ing, was 725 sec.
In addition, synaptic transmission recovered faster during the
second and subsequent hypoxic episodes. For example, 2.5 min
after the return to normoxia, synaptic transmission had recovered
to 29.0 6 8.3% of control after the first 10 min hypoxic episode.
At the same time point, transmission had recovered to 60.6 6
8.2% of control after the second 10 min hypoxic episode (paired
t test, p 5 0.01; n 5 9; data not shown).
To ensure that conditioning did not reflect some time-
dependent change in the integrity of the hippocampal slice, such
as the gradual loss of adenosine, we placed slices in the recording
chamber and measured synaptic transmission for ;90 min beyond
the initial stabilization period of ;30 min. A gradual loss of
adenosine would be expected to result in a longer t50 value.
However, after this protracted incubation period, t50 measured
82 6 4 sec (n 5 15) and was not significantly different (unpaired
t test, p . 0.3) from interleaved controls given a 30 min stabili-
zation period (t50 5 77 6 3 sec; n 5 26). Furthermore, the period
of incubation had no influence (unpaired t test, p . 0.4) on the
extent of conditioning after an initial 10 min hypoxic episode
[Dt50 5 42 6 3 sec (n 5 26) and 37 6 4 sec (n 5 15) for 30 and
90 min incubation, respectively].
Figure 2. Exposure to hypoxia results in reduced sensitivity of synaptic
transmission to subsequent hypoxia. A, A typical experiment in which two
sequential hypoxic episodes were given to the same slice. A(1) shows fEPSP
slope versus time. Labeled at time points a through f are fEPSPs (inset
above, stimulus artifacts are truncated) before (a, d), during (b, e), and after
(c, f ) two sequential hypoxic episodes (10 and 5 min, respectively). A(2),
Superimposition of normalized data from the first 4 min of each hypoxic
episode (f, first episode; E, second episode). Notice the resistance (con-
ditioning) of the fEPSP to hypoxia during the second episode. The super-
imposed fEPSPs (b, e), both taken 2 min into the hypoxic episode, highlight
this apparent acquired resistance to the effects of hypoxia. Calibration: 10
msec, 0.4 mV. B, Conditioning depends on the duration of the first hypoxic
episode. Insets show pooled normalized data of the influence of the dura-
tion of the first hypoxic episodes (f) of (from lef t to right) 2.25 (n 5 11), 10
(n 5 24), and 40 min (n 5 21) on the decay of the fEPSP during the second
hypoxic episode (E). Graph shows dependence of conditioning, expressed
as the difference between the time to 50% depression of the fEPSP of the
first and second episodes (Dt50: 2.25 min, n 5 11; 5 min, n 5 32; 10 min, n 5
94; 20 min, n 5 10; 40 min, n 5 27) on the duration of initial hypoxic
episode. Line through points follows the equation given in Results and gives
a time constant of conditioning of 725 sec.
Figure 1. Role of adenosine A1 receptors in the hypoxic depression of
excitatory synaptic transmission. Pooled data, normalized to the prehy-
poxic fEPSP slope, for control (F; n 5 24) and 200 nM DPCPX-treated
(L; n 5 5) slices showing the effect of a single 10 min hypoxic episode
(denoted by the black bar). Inset shows typical fEPSPs taken at the time
points indicated, before (a, d), during (b, e), and after (c, f ) the hypoxic
episode: control (a–c); 200 nM DPCPX (d–f ). Note the differences in the
fEPSPs at time points (b) and after (e) 3 min of hypoxia reflecting the A1
receptor-dependence of the hypoxic depression of the fEPSP. Calibra-
tion: 10 msec, 0.4 mV.
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Conditioning is observed under whole-cell
voltage clamp
To test whether conditioning occurred at the level of single cells,
we performed whole-cell voltage-clamp recordings from CA1
neurons. One neuron per slice was exposed to two sequential 5 or
10 min hypoxic episodes. The hypoxic depression of the EPSC
was greatly attenuated by DPCPX (200 nM; 20.7 6 10.0% depres-
sion after 10 min of hypoxia; n 5 14) (Fig. 3) compared with the
hypoxic depression in the absence of DPCPX (81.0 6 2.3%; n 5
70). In cells that were exposed to a first hypoxic episode of 5 min
duration, we observed conditioning of 35 6 9 sec (n 5 4; p 5
0.034, paired t test; data not shown). In 25 cells exposed to two 10
min hypoxic episodes, the majority (20; 80%) showed a slower
rate of decay of the EPSC during the second hypoxic episode
(Dt50 5 64 6 9 sec) (Fig. 4). A small number of the cells (5; 20%)
showed a depression of the EPSC during the second hypoxic
episode, which was faster than the depression of the first (Dt50 5
297 6 10 sec; data not shown). For both groups there was no
significant change in holding current, series resistance, or input
resistance between the first and second hypoxic episodes ( p .
0.05; paired t test). In addition, the differences between the two
groups on the rate of depression of the EPSC during the second
hypoxic episode could not be explained in terms of either a
difference in any of these parameters or the length of recording
( p . 0.05; unpaired t test).
Neither impaired adenosine transport nor receptor
desensitization is responsible for conditioning
One mechanism that controls the concentration of extracellular
adenosine is the equilibrative adenosine transporter. The delay in
the depression of synaptic transmission during the second expo-
sure to hypoxia could reflect an alteration of adenosine transport
into or out of the synaptic cleft. We tested this with a combination
of adenosine uptake inhibitors: DIPY at 5 mM and NBTI at 1 mM
(cf. Dunwiddie and Diao, 1994). This combination of inhibitors
resulted in a profound depression (67.2 6 5.9%; n 5 8) of the
fEPSP (Fig. 5A). Indeed in 3/11 slices, synaptic transmission was
depressed by $90% of control and was not analyzed further. The
synaptic depression induced by DIPY/NBTI was fully reversed
(102.3 6 10.5%; n 5 5) by the selective A1 antagonist DPCPX
(200 nM) (Fig. 5A), indicating the specificity of the depression of
transmission by DIPY/NBTI to an accumulation of extracellular
adenosine and activation of presynaptic A1 receptors. In five
additional experiments (data not shown), this synaptic depression
was maintained in the continued presence of DIPY/NBTI for 90
Figure 3. Role of adenosine A1 receptors in the hypoxic depression of
excitatory synaptic transmission under whole-cell voltage-clamp condi-
tions. Pooled data, normalized to the prehypoxic EPSC amplitude, for
control (f; n 5 70) and 200 nM DPCPX-treated (L; n 5 14) slices show
the effect of a single 10 min hypoxic episode (denoted by the black bar).
Inset shows typical EPSCs taken at the time points indicated, before (a,
d), during (b, e), and after (c, f ) the hypoxic episode: control (a–c); 200 nM
DPCPX (d–f ). Note the differences in the fEPSPs at time points b and e
after 10 min of hypoxia reflecting the A1 receptor-dependence of the
hypoxic depression of the EPSC. Calibration: 40 msec, 50 pA.
Figure 4. Reduced sensitivity of whole-cell voltage-clamp EPSCs to
hypoxia. A, Effect of two 10 min periods of hypoxia on EPSC during an
individual experiment. Note reduced rate of depression of the EPSC
during the second hypoxic episode (E) compared with the first (f). Inset
shows EPSCs taken at the times indicated. Calibration: 30 msec, 50 pA.
B, Pooled data from 20 cells in which cells were exposed to two sequential
10 min periods of hypoxia (first episode, f; second episode, E). Note
increased resistance to the effects of hypoxia during the second hypoxic
episode.
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min (;75% depression at 90 min), indicating the lack of signifi-
cant adenosine washout from the extracellular space.
DIPY/NBTI failed to prevent the hypoxic depression of syn-
aptic transmission (t50(1) 5 68 6 10 sec; n 5 8). This rate of
depression was not significantly different from control (t50(1)5
88 6 5 sec; n 5 32; unpaired t test, p 5 0.1). However, DIPY/
NBTI significantly ( p , 0.01, unpaired t test) delayed the recov-
ery of synaptic transmission after hypoxia: after 2.25 min of
normoxia the fEPSP had recovered to 50.5 6 7.4% in control
aCSF (n 5 21), whereas at this time transmission had only
recovered to 17.1 6 3.2% in DIPY/NBTI (n 5 8). Moreover,
DIPY/NBTI failed to prevent significant conditioning (Dt50 5
29 6 8 sec; p 5 0.006, paired t test; n 5 8) or alter its magnitude
(unpaired t test, p 5 0.79) when compared with controls (Fig. 5A,
inset). This indicates first, that reversed adenosine transport may
not contribute greatly to the accumulation of adenosine during
hypoxia, and second, that impaired adenosine transport does not
underlie conditioning. The prolonged exposure to high extracel-
lular levels of endogenous adenosine also suggests that desensi-
tization of A1 receptors is unlikely to underlie conditioning.
We further tested the possible role of A1 receptor desensitiza-
tion by applying exogenous adenosine (100 mM) sufficient to
almost completely abolish the fEPSP under normoxic conditions
(Fig. 5B). Two sequential applications of 100 mM adenosine, each
of 10 min duration, resulted in virtually identical rates of depres-
sion of the fEPSP (Dt50 5 1 6 3 sec; n 5 6; paired t test, p . 0.22).
Five additional experiments were performed in which two 5 min
applications of 60 mM adenosine were interleaved between a 10
and 5 min hypoxic episode (data not shown). In these experi-
ments significant hypoxic conditioning was observed (Dt(50) 5
43 6 8 sec; n 5 5; paired t test, p , 0.006), but there was no
significant change in the rate at which exogenous adenosine (60
mM) depressed the fEPSP (Dt(50) 5 1 6 2 sec; paired t test, p .
0.7; n 5 5). Our data therefore make it very unlikely that A1
receptor desensitization could underlie conditioning.
Reduced extracellular adenosine
underlies conditioning
Activation of A1 receptors on presynaptic glutamatergic terminals
largely causes the hypoxic depression of excitatory synaptic trans-
mission in area CA1 (Figs. 1, 3). Conditioning therefore may
reflect a reduced rate or amount of adenosine production during
Figure 5. Conditioning depends on a reduction in
extracellular adenosine and not changes in aden-
osine transport or A1 receptor desensitization. A,
Incubation with the adenosine transport inhibitors
NBTI (1 mM) and DIPY (5 mM), denoted by bar,
greatly depressed the fEPSP (n 5 8). When the
depression had stabilized, two sequential 5 min
hypoxic episodes (each denoted by a bar) were
administered. This resulted in a complete depres-
sion of synaptic transmission and conditioning of
the fEPSP that was no different ( p 5 0.82; un-
paired t test) from that in the absence of NBTI/
DIPY (inset histogram; NBTI/DIPY, n 5 8; con-
trol, n 5 32). Application of DPCPX (200 nM; n 5
5), denoted by bar, confirmed the NBTI/DIPY-
induced depression as being dependent on A1 re-
ceptors. Break in time course plot reflects ;30
min. B, Pooled normalized data of fEPSP depres-
sions to two sequential 10 min applications of 100
mM adenosine on the fEPSP (Dt50 5 1 6 3 sec; n 5
6). C, Pooled normalized data of fEPSP depres-
sions to hypoxia while in the presence of 10 nM
DPCPX (n 5 7; f, first hypoxic episode; M, sec-
ond hypoxic episode) and for comparison controls
(n 5 24; F, first hypoxic episode; E, second hy-
poxic episode). For clarity, the shaded bars repre-
sent the Dt50 values for the control experiments
(lef t) and DPCPX experiments (right). Inset is a
histogram comparing the magnitude of condition-
ing in control (n 5 94) and 10 nM DPCPX-treated
slices (n 5 7). DPCPX-treated slices exhibited
significantly greater conditioning (Student’s t test,
p , 0.0001), indicating a reduction in extracellular
adenosine as the basis of conditioning.
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hypoxia and thus weaker activation of A1 receptors. We tested
this by using the competitive A1 antagonist DPCPX. If condition-
ing involved reduced adenosine in the extracellular space during
a second hypoxic episode, a low concentration of the competitive
antagonist DPCPX should exaggerate conditioning because it will
out-compete the lower concentrations of endogenous adenosine
that we predict should occur in the synaptic cleft during repeated
hypoxia. Because of the partial antagonism of the A1 receptors,
the rate of depression was significantly slowed in the presence of
10 nM DPCPX (t50(1) 5 252 6 44 sec; n 5 7) (Fig. 5C) when
compared with controls (80 6 2 sec; n 5 165; p , 0.0001,
unpaired t test). However, the depression of the fEPSP during the
second hypoxic episode was greatly retarded such that condition-
ing in the presence of 10 nM DPCPX (Dt50 5 119 6 38 sec; n 5
7) was significantly greater than in the control (Dt50 5 48 6 2; n 5
94; p , 0.0001, unpaired t test) (Fig. 5C, inset). This result
therefore suggests that conditioning reflects reduced adenosine in
the synaptic cleft during the second and subsequent hypoxic
episodes.
Direct demonstration of reduced extracellular
adenosine in response to repeated hypoxia
Direct measurement of adenosine release confirms the hypothesis
that conditioning is associated with reduced adenosine produc-
tion during repeated hypoxia. Exposure to an initial 5 min hy-
poxic episode resulted in 3.9 6 0.9 mM (n 5 8) adenosine being
recorded by the sensor on the surface of the slice. A subsequent
5 min episode delivered ;30 min later resulted in the release of
significantly less adenosine (2.0 6 0.4 mM; n 5 8; paired t test, p 5
Figure 6. Direct measurement of reduced adenosine release during
repeated hypoxia. A, Output from the adenosine sensor during two
sequential 5 min periods of hypoxia (black bar and between upward
deflections of chart event marker). Note reduced adenosine release during
second hypoxic episode. Calibration: 2 mM adenosine, 3 min. Break in
chart record reflects ;17 min. B, Field EPSPs taken at the times indicated
in C. Calibration: 10 msec, 0.25 mV. C, Time course of hypoxic depression
of fEPSP showing slower rate of depression (c vs d), similar maximal
depression (e vs f ), and more rapid recovery of transmission ( g vs h)
during the second hypoxic episode (E) compared with the first (f).
Figure 7. Adenosine depletion in nominally Ca 21-free aCSF. Two se-
quential 5 min periods of hypoxia (black bars and upward deflections of
chart event markers) separated by 30 min in a slice incubated in nominally
Ca 21-free aCSF (2 mM Ca 21 replaced by 2 mM Mg 21) for .3 hr. Note
large decrease in adenosine release in response to the second hypoxic
episode. Calibration: 5 mM, 5 min.
Figure 8. Depletion of adenosine production during successive hypoxic
episodes. Pooled data from three different experimental protocols show-
ing the minute-by-minute profile of adenosine release during the first (f)
and second (E) hypoxic episodes (denoted by black bar). A, Two sequen-
tial 5 min hypoxic episodes in 2 mM extracellular Ca 21 (n 5 8); B, two
sequential 10 min hypoxic episodes in 2 mM extracellular Ca 21 (n 5 8); C,
two sequential 5 min hypoxic episodes in nominally Ca 21-free aCSF (2 mM
Ca 21 replaced with 2 mM Mg 21; n 5 6).
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0.006) (see Fig. 8A). This 49.5 6 5% (n 5 8) reduction in
adenosine release was associated with conditioning of 14 6 7 sec
(range, 221–55 sec; n 5 8) (Fig. 6). Experiments in which the first
hypoxic episode lasted 10 min caused the release of 9.6 6 1.8 mM
adenosine (n 5 9). A subsequent 10 min episode resulted in
significantly less adenosine release (7.0 6 1.4 mM; n 5 9; paired t
test, p 5 0.04) (see Fig. 8B) and was associated with 27 6 6 sec of
conditioning (range, 12–68 sec; n 5 9). In these experiments
considerable variation was seen in the adenosine released during
the second hypoxic episode such that overall the reduction in
adenosine release during the second 10 min hypoxic episode
measured 18.6 6 10.4% (range, 242.1–70.4%; n 5 9). However,
a significant positive correlation (r 5 0.7; p 5 0.03; n 5 9) was
seen between the extent of conditioning and the reduction in
adenosine release.
We also observed that hypoxic adenosine production, although
not dependent on extracellular calcium (indeed it is inhibited by
extracellular calcium) was vulnerable to depletion in nominally
calcium-free aCSF (Fig. 7). In these experiments, slices were
incubated for 3–6 hr in aCSF in which the calcium was replaced
by 2 mM Mg21. As reported previously, adenosine production was
greatly enhanced during hypoxia under these conditions (Pedata
et al., 1993; Dale et al., 2000). The adenosine released during the
first 5 min hypoxic episode measured 48.9 6 17.7 mM (n 5 6).
However, sequential exposure to as little as 5 min of hypoxia
resulted in a massive reduction (61.4 6 7.7%) in extracellular
adenosine during the second hypoxic episode (16.6 6 5.2 mM; n 5
6; Wilcoxon matched-pairs signed-ranks test, p 5 0.028) (Fig. 8C).
This reduction was not caused by nonspecific cellular deteriora-
tion of the slice because the fEPSP returned when perfused with
standard 2 mM Ca21-containing aCSF (data not shown).
Restoration of adenosine release
We attempted to restore depleted levels of adenosine release by
perfusing slices with exogenous adenosine. In this series of ex-
periments, conditioning and depletion of adenosine release were
induced by an initial 40 min hypoxic episode. This was followed
by two 5 min test periods of hypoxia to measure the extent of
conditioning, and then perfusion with 20 mM adenosine for 15
min to attempt to restore or replenish the levels of adenosine
production (Fig. 9A). A final 5 min test period of hypoxia after
adenosine washout was administered to measure the extent of
conditioning before and after the attempted replenishment. A
time control was conducted in an interleaved series of experi-
ments in which no adenosine was perfused between the third and
fourth hypoxic episodes (Fig. 9A). A further control specifically
for A1 receptor activation, perfusion with the metabolically stable
adenosine analog 30 nM N 6CPA (Fig. 9A), was also interleaved.
The exogenous application of adenosine resulted in replenish-
ment of adenosine release, seen as a significant reversal of con-
ditioning between the third and final hypoxic episodes (Dt50 5
215 6 7 sec; n 5 10; p , 0.05, unpaired t test). In contrast, both
the time control and the 30 nM N6CPA experiments exhibited
additional adenosine depletion seen as a further increase in
conditioning (Dt50 5 9 6 7 sec; n 5 6 and 5 6 4 and n 5 9,
respectively).
We next determined whether the slice had the capacity to
restore adenosine release from endogenous sources. This homeo-
static mechanism must be slow because there was no significant
difference ( p . 0.9; unpaired t test) in conditioning between
slices exposed to a 10 min hypoxic episode with a brief (;12 min;
Dt50 5 48 6 2 sec; n 5 94) inter-episode interval and slices in
which the inter-episode interval was of intermediate duration (45
min; Dt50 5 48 6 10 sec; n 5 10). This suggests that a single
exposure to hypoxia can influence the subsequent hypoxic de-
Figure 9. Replenishment of the depleted adenosine. A, Exogenous aden-
osine replenishes the depleted adenosine. After one 40 and two 5 min
hypoxic episodes, slices were exposed to 20 mM adenosine (ADO; n 5 10)
or 30 nM N 6CPA (N6CPA; n 5 9) or allowed to rest for an equivalent time
(15 min; REST; n 5 6). A fourth 5 min hypoxic episode was then
administered (inset: experimental protocol). A comparison was then
made between the t50 values of the third and fourth hypoxia-induced
depressions of the fEPSP (Dt50(4–3); in bold in protocol). The bar chart
shows that the application of adenosine, but not of the selective A1 agonist
N 6CPA or an equivalent rest period, results in an acceleration of the rate
of depression of the fEPSP by hypoxia ( p , 0.05, unpaired t test). B,
Replenishment by endogenous adenosine. Experiment in which a 10 (f;
dashed line) and 5 (M) min hypoxic episode was followed by a second 10
(F) min episode after a short interval (;10 min; n 5 13; top) or after a
2 hr interval (1209; n 5 13; bottom). With a short rest, hypoxia causes
further conditioning (rightward shift) between the second (M) and third
(F) hypoxic episodes. However, a prolonged rest period of 2 hr between
the second (M) and third (F) hypoxic episodes causes the third exposure
to hypoxia to induce a more rapid depression of the fEPSP (leftward shift)
throughout the hypoxic episode. These data argue for a replenishment of
the depleted adenosine and against gradual deterioration in slice viability.
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pression of synaptic transmission for a considerable length of time
and further argues against a gradual deterioration in slice viabil-
ity as the basis of conditioning.
We therefore examined whether replenishment from endoge-
nous sources might occur over a longer time scale by using
another experimental protocol in which three hypoxic episodes
were administered (Fig. 9B). The first two episodes allowed
measurement of the extent of conditioning within each slice. The
third episode, given after a delay of either ;10 or 120 min,
allowed the comparison of the influence of the protracted rest
period on the rate of hypoxic depression of the fEPSP. In the
control group, slices were exposed to two hypoxic episodes of 10
and 5 min duration and then left to recover for only ;10 min
before retesting with another hypoxic episode (10 min). These
slices showed further conditioning on either side of the 10 min
rest period (Dt50(3–2) 5 6 6 4 sec; n 5 13). In the experimental
group, slices were allowed to recover for 120 min between the
second and third hypoxic episodes. In direct contrast to the
controls, these slices showed an acceleration in the rate at which
hypoxia depressed synaptic transmission on either side of the rest
period (Dt50(3–2); 212 6 7 sec; n 5 13; p 5 0.03 vs control,
unpaired t test). The accelerated rate of depression after the rest
period suggests that the slice is able, albeit rather slowly, to
replenish adenosine release from endogenous sources. Further-
more, our results indicate that it is possible to observe and study
this potentially important process of replenishment in vitro.
DISCUSSION
A depletable pool of adenosine: a working model
We have documented that with repeated episodes of hypoxia, the
levels of adenosine production fall. This observation could result
from a weakening of the release process itself, which may include
some change in the intracellular formation of adenosine, a
strengthening of reuptake mechanisms or, if adenosine is not
released directly, a weakening of ectoenzyme activity. One dis-
tinct possibility is that the weakening of adenosine production
reported here reflects depletion of adenine nucleotides (cf. Siesjo
and Wieloch, 1985). We cannot discriminate among these possi-
bilities at this stage, but our experiments with the uptake inhib-
itors DIPY and NBTI make changes in reuptake unlikely. We
propose the existence of a depletable pool of adenosine or pre-
cursor as being the simplest interpretation of our findings. This
pool is accessed by metabolic stress, in our case hypoxia, which
results in reduced availability of adenosine for a considerable
time thereafter. During this time a subsequent hypoxic episode is
less effective at depressing excitatory synaptic transmission. In the
young rats used in this study, the slowing of the depression of
excitatory transmission depends critically on the severity of the
initial hypoxic episode but can be observed at both the population
(field recordings) and single-cell level (patch-clamp recordings).
Because the neuronal response to metabolic stress varies with age
(Cherubini et al., 1989; Yager and Thornhill, 1997), it remains to
be seen whether adenosine depletion also varies with maturation.
Because the contributions from CA3 neurons, GABAergic inhi-
bition, and postsynaptic depolarization were removed or con-
trolled for in the patch-clamp experiments, these mechanisms are
unlikely to contribute to the changes in rate of synaptic depres-
sion seen with repeated hypoxia.
Although the dramatic enhancement of hypoxic/ischemic
adenosine release in calcium-free medium has been demonstrated
previously (Pedata et al., 1993; Dale et al., 2000), we have shown
that the depletion of adenosine is particularly extensive in nom-
inally calcium-free aCSF. This may reflect the greatly enhanced
release or a calcium-dependency of replenishment. The mecha-
nism underlying the increased release and depletion during hyp-
oxia in nominally calcium-free aCSF is unclear, but it does not
rely on gross pathological cell lysis because synaptic transmission
indistinguishable from control was obtained on perfusion with
normal calcium-containing aCSF. Local reductions in extracellu-
lar calcium (Rusakov et al., 1999) during repetitive synaptic or
seizure activity or during hypoxia/ischemia may influence the
rate at which the adenosine pool is released (Dale et al., 2000),
depleted, or replenished.
Replenishment of adenosine release
An important finding of our study is that replenishment of aden-
osine release is possible by both endogenous and exogenous
mechanisms. The former likely exploits mechanisms within the
CNS to either sequester ambient adenosine or synthesize aden-
osine from precursors. The latter offers scope for exogenous,
therapeutic intervention in conditions ameliorated by adenosine.
The extent of endogenous replenishment is slow and weak under
the present circumstances, but the fact that it can be observed at
all indicates that depletion is not a progressive deterioration in
the viability of the slice. Furthermore, it indicates that condition-
ing does not merely reflect nonspecific washout of adenosine from
the slice, because t50 remained stable over time, transmission
remained fully depressed for the 40 min duration of the hypoxic
episode [see also Arlinghaus and Lee (1996)], and prolonged (90
min) incubation in uptake inhibitors resulted in a sustained de-
pression of transmission.
Purine loss from the CNS in vivo
An important issue is the extent to which the adenosine loss we
have described in vitro occurs in vivo. Reduced release of adeno-
sine after repeated global ischemia at 2 hr intervals was observed
in an in vivo microdialysis study (Valtysson et al., 1998). The same
study reported the enhanced production of xanthine after isch-
emia, which, as a nonsalvageable product of purine metabolism,
represents a source of adenosine loss. These findings may reflect
the depletion of adenine nucleotides after metabolic stress and
the slow nature of their synthesis such that energy charge is
reestablished several hours before the nucleotide pool is restored
(Siesjo and Wieloch, 1985). Furthermore, the very high density of
equilibrative adenosine transporters in the mammalian blood–
brain barrier (Kalaria and Harik, 1986) implies that increases in
intracerebral adenosine are cleared rapidly and that the CNS may
actually lose adenosine to the systemic circulation in vivo. Indeed,
several clinical studies have measured sustained increases in sys-
temic blood adenosine levels in humans suffering from stroke and
transient ischemic attack (Laghi-Pasini et al., 2000) or experienc-
ing cerebral ischemia during carotid endarterectomy (Weigand et
al., 1999). Although our in vitro model may not reflect all aspects
of adenosine depletion in vivo, it does allow the consequences of
adenosine depletion for neuronal function to be studied directly
and in isolation.
Implications for neuroprotection by adenosine
The vital modulatory role of adenosine in the mammalian CNS
extends to its accumulation during periods of metabolic or trau-
matic stress (Rudolphi et al., 1992; Sweeney, 1997; Von Lubitz,
1999). It is therefore surprising and counterintuitive to discover
that this vital role can be compromised by a brief exposure to
sublethal hypoxia or ischemia. The functional ramifications of
this are manifold and serious. In the first instance, as presented
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here, excitatory glutamatergic transmission will persist for longer
during hypoxia/ischemia. This will allow potentially pathological
activation of postsynaptic glutamate receptors at a time when the
ATP production necessary to maintain neuronal integrity is com-
promised. In addition, the postsynaptic hyperpolarization medi-
ated by adenosine will be lessened. Thus, reduced adenosine in
the synaptic cleft favors increased glutamate release, postsynaptic
depolarization, glutamate receptor activation, and postsynaptic
calcium influx during both the onset of metabolic stress and
reperfusion. In addition, a reduction in CNS adenosine will result
in less vasodilatation of the cerebral vasculature reducing oxygen/
glucose delivery to the brain. In total, the implications of a
reduction in adenosine availability are likely to have serious
consequences for the intact brain, a plausible explanation for the
increased sensitivity of the in vivo brain to repeated brief
hypoxia/ischemia.
Many studies have found that repeated sublethal episodes (2–3
min) greatly exacerbate the biochemical changes associated with
hypoxia/ischemia (Mrsulja et al., 1977), including increased cal-
cium accumulation within neurons (Kato et al., 1989), and initiate
destruction of selectively vulnerable neurons in area CA1, stria-
tum, and thalamus (Kato et al., 1989; Kato and Kogure, 1990),
resulting in infarction (Kato et al., 1992). Because NMDA recep-
tor antagonists prevent the neuronal death associated with re-
peated brief ischemia (Kato et al., 1990), increases in extracellu-
lar glutamate may underlie this phenomenon. However, the
evidence is contradictory regarding whether repeated brief isch-
emia augments glutamate release (Lin et al., 1992; Nakata et al.,
1992). The mechanism that we propose, of reduced adenosine
release, would accommodate either scenario because even the
same amount of glutamate release would be expected to result in
greater neuropathology.
In vivo maximal vulnerability occurs 1 hr after the initial
hypoxic/ischemic episode. At this time, minimal replenishment
of the adenosine pool would be expected. However, at shorter
intervals, extracellular levels of adenosine may still be elevated
(Valtysson et al., 1998) and, in tandem with depressed excitatory
synaptic transmission, may promote neuroprotection (Perez-
Pinzon et al., 1997; Stagliano et al., 1999). At longer intervals (.4
hr), adenosine levels may be at least partially replenished. Even
longer inter-episode intervals (24 hr) give rise to ischemic pre-
conditioning (Chen and Simon, 1997) wherein neuropathology is
reduced. Given the long delay before protective preconditioning
is seen in vivo and the requirement for protein synthesis, the
extent to which protective preconditioning can be studied in vitro,
over the time course of the present experiments, is questionable.
Studies reporting a more rapid and complete recovery or poten-
tiations of transmission after brief ischemia in vitro may reflect a
reduction in extracellular adenosine rather than the induction of
a protective mechanism applicable to the in vivo situation.
In addition to offering an explanation for the increased vulner-
ability of the brain after hypoxia/ischemia, the concept of a
depletable pool of CNS adenosine provides a plausible basis for
the sensitization of brain tissue after head injury or after status
epilepticus. Both cause adenosine release that if lost, either to the
systemic circulation (Weigand et al., 1999; Laghi-Pasini et al.,
2000) or to nonsalvageable xanthine (Valtysson et al., 1998),
would compromise the ability of the brain to protect itself during
subsequent hypoxia/ischemia. That these conditions do indeed
result in the diminished availability of adenosine is supported by
reduced hypoxic vasodilatation after status epilepticus [which has
been proposed to involve less adenosine release (DiGeronimo et
al., 1998)] and the reduced cerebral blood flow after head injury
(Lewelt et al., 1982). Indeed, entry into status epilepticus may
result from an attenuation or loss of adenosinergic tone after
previous seizure activity (Young and Dragunow, 1994).
Our findings provide direct evidence for the existence of a
depletable, but replenishable, pool of adenosine in the mamma-
lian CNS. The actual nature of the pool remains to be clarified
but may involve adenosine per se, a precursor, or an enzyme or
transport system, ultimately resulting in the accumulation of
adenosine in the extracellular space. The ability to investigate
this pool in vitro offers the opportunity to explore novel thera-
peutic avenues relating to various human clinical conditions in
which intervention may reduce the severity of secondary central
metabolic stress.
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